As of 2025-09-13, the Relative Valuation of Eli Lilly and Co (LLY) is 337.16 USD. This relative valuation is based on P/E multiples. With the latest stock price at 755.39 USD, the upside of Eli Lilly and Co based on Relative Valuation is -55.4%.
The range of the Relative Valuation is 240.84 - 564.56 USD.
| Range | Selected | |
| Trailing P/E multiples | 26.5x - 38.7x | 28.7x |
| Forward P/E multiples | 18.1x - 20.3x | 19.2x |
| Fair Price | 240.84 - 564.56 | 337.16 |
| Upside | -68.1% - -25.3% | -55.4% |
| Date | P/E |
| 2025-09-12 | 51.81 |
| 2025-09-11 | 51.87 |
| 2025-09-10 | 51.76 |
| 2025-09-09 | 51.48 |
| 2025-09-08 | 50.66 |
| 2025-09-05 | 49.88 |
| 2025-09-04 | 50.95 |
| 2025-09-03 | 50.60 |
| 2025-09-02 | 50.42 |
| 2025-08-29 | 50.24 |
| 2025-08-28 | 50.20 |
| 2025-08-27 | 50.35 |
| 2025-08-26 | 50.48 |
| 2025-08-25 | 47.69 |
| 2025-08-22 | 48.81 |
| 2025-08-21 | 48.68 |
| 2025-08-20 | 48.38 |
| 2025-08-19 | 48.23 |
| 2025-08-18 | 47.88 |
| 2025-08-15 | 48.09 |
| 2025-08-14 | 46.94 |
| 2025-08-13 | 45.30 |
| 2025-08-12 | 43.86 |
| 2025-08-11 | 43.57 |
| 2025-08-08 | 42.91 |
| 2025-08-07 | 43.95 |
| 2025-08-06 | 51.19 |
| 2025-08-05 | 52.53 |
| 2025-08-04 | 52.74 |
| 2025-08-01 | 52.28 |
| 2025-07-31 | 50.76 |
| 2025-07-30 | 52.13 |
| 2025-07-29 | 52.33 |
| 2025-07-28 | 55.42 |
| 2025-07-25 | 55.74 |
| 2025-07-24 | 55.24 |
| 2025-07-23 | 54.79 |
| 2025-07-22 | 53.25 |
| 2025-07-21 | 52.27 |
| 2025-07-18 | 52.93 |
| 2025-07-17 | 52.23 |
| 2025-07-16 | 54.17 |
| 2025-07-15 | 52.93 |
| 2025-07-14 | 54.82 |
| 2025-07-11 | 54.39 |
| 2025-07-10 | 54.23 |
| 2025-07-09 | 53.97 |
| 2025-07-08 | 53.34 |
| 2025-07-07 | 53.01 |
| 2025-07-03 | 53.54 |